CDTX vs EG · rev $1.3M vs P/E 17, rev $17.28B
Cidara Therapeutics Inc (CDTX) versus Everest Group Ltd (EG) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported EG revenue for 2024-12-31 was $17.28B. Net income was $1.37B. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. EG currently screens at market cap $14.52B and trailing P/E 17.2.
CDTX currently screens at market cap $6.96B. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Not investment advice. Open the CDTX and EG stock pages for the full models.
Not investment advice.